Date | Title | Description | |
---|---|---|---|
10 May 2023 | On P&L | The Company releases the first quarter 2023 financial results presentation | Download |
10 May 2023 | On P&L | The Company releases the press release related to the first quarter 2023 financial results | Download |
25 Apr 2023 | On business and financial situation | ROVI commences clinical development of a new three-monthly formulation of Letrozole (Letrozole LEBE) | Download |
21 Feb 2023 | On business and financial situation | The Company releases the full year 2022 financial results presentation. | Download |
21 Feb 2023 | On business and financial situation | The Company releases the press release related to the full year 2022 financial results. | Download |
Pages
Date | Title | Description | |
---|---|---|---|
21 Oct 2021 | Liquidity and counterparty agreements | Download | |
07 Oct 2021 | Liquidity and counterparty agreements | Download | |
04 Oct 2021 | Liquidity and counterparty agreements | Download | |
01 Sep 2021 | On business and financial situation | ROVI informs about the joint statement from Moderna and Takeda on the investigation of suspended lots of the vaccine | Download |
28 Jul 2021 | On business and financial situation | The company releases the press release related to first half 2021 financial results | Download |
Pages
Date | Title | Description | |
---|---|---|---|
31 May 2017 | Convocatorias y Acuerdos de Juntas y Asambleas Generales | ROVI releases the information related to its General Shareholders Meeting | Download |
26 Apr 2017 | Convocatorias y Acuerdos de Juntas y Asambleas Generales | ROVI informs about the call for the 2017 Ordinary General Shareholders Meeting | Download |
21 Apr 2017 | Convocatorias y Acuerdos de Juntas y Asambleas Generales | ROVI informs about the call for the General Shareholders Meeting | Download |
21 Apr 2017 | Información sobre resultados | ROVI releases the press release related to the 2017 first quarter results. | Download |
21 Apr 2017 | Información sobre resultados | ROVI releases the presentation related to the 2017 first quarter results | Download |